| - - | |
|---|---|
| Price | |
| - | |
| Difference | - (-) |
General attributes
| ISIN | NL0000009827 |
| Symbol | 8010908149 |
| Exchange | - |
| Currency | - |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 764 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | - |
| High | - |
| Low | - |
| Close (prev. day) | - |
| VWAP | - |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | - |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: KONINKLIJKE DSM NV |  |
Add Benchmark:
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| - - | |
|---|---|
| Price | |
| - | |
| Difference | - (-) |
General attributes
| ISIN | NL0000009827 |
| Symbol | 8010908149 |
| Exchange | - |
| Currency | - |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 764 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | - |
| High | - |
| Low | - |
| Close (prev. day) | - |
| VWAP | - |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | - |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -5.28% | -20.28% | -0.52% |
| Perf (abs.) | -6.35 | -29.00 | -0.60 |
| Beta | 0.00 | -0.07 | 0.07 |
| Volatility | 26.39 | 31.94 | 26.76 |
Add Benchmark:
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 113.55 - (10) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 115.21 - (3) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 116.79 - (2) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 124.51 - (2) |
| YTD High | date | 125.35 - (2023/02/09) |
| YTD Low | date | 107.70 - (2023/04/06) |
| 52 Weeks High | date | 158.35 - (2022/06/01) |
| 52 Weeks Low | date | 107.70 - (2023/04/06) |
Company Logo
Contact Details
| DSM BV |
| - - |
| Het Overloon 1 - 6411 TE Heerlen |
| Telefon: +31-45-578-28-64 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: KONINKLIJKE DSM NV | |
Company Profile
DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. |
Members of Management Board
| Dimitri de Vreeze | Chairman of Managing Board |
| Géraldine Matchett | Chairman of Managing Board |
Board of directors
| Thomas Leysen | Chairman of Supervisory Board |
| Corien M. Wortmann-Kool | Member of Supervisory Board |
| John Ramsay | Member of Supervisory Board |